Together with G protein-coupled receptor (GPCR) kinases (GRKs) and -arrestins, RGS proteins are the major family of molecules that control the signaling of GPCRs. The expression pattern of one of these RGS family members, RGS9-2, coincides with that of the dopamine D 3 receptor (D 3 R) in the brain, and in vivo studies have shown that RGS9-2 regulates the signaling of D2-like receptors. In this study, -arrestin2 was found to be required for scaffolding of the intricate interactions among the dishevelled-EGL10-pleckstrin (DEP) domain of RGS9-2, G5, R7-binding protein (R7BP), and D 3 R. The DEP domain of RGS9-2, under the permission of -arrestin2, inhibited the signaling of D 3 R in collaboration with G5. -Arrestin2 competed with R7BP and G5 so that RGS9-2 is placed in the cytosolic region in an open conformation which is able to inhibit the signaling of GPCRs. The affinity of the receptor protein for -arrestin2 was a critical factor that determined the selectivity of RGS9-2 for the receptor it regulates. These results show that -arrestins function not only as mediators of receptor-G protein uncoupling and initiators of receptor endocytosis but also as scaffolding proteins that control and coordinate the inhibitory effects of RGS proteins on the signaling of certain GPCRs.The regulation of G protein-coupled receptors (GPCRs) involves various cellular events in different time frames, and the detailed regulatory mechanism can be unique for each receptor type and the signal it mediates. Much of our knowledge concerning the molecular basis of homologous desensitization of GPCRs is derived from studies of the  2 -adrenergic receptor ( 2 AR), in which GPCR kinases (GRKs) and -arrestins play central roles. According to this working model, GRK-mediated receptor phosphorylation, followed by the association of -arrestin, causes uncoupling of the GPCR from the G protein (16,18,30). However, the detailed molecular mechanism of this uncoupling of receptors from the G protein is unclear, aside from the simple idea that -arrestins could physically interfere with the interaction between the receptor and G protein.Upon agonist binding, GPCRs stimulate the conversion of the inactive heterotrimeric GTP-binding protein GDP-G␣␥ to GTP-G␣ and G␥. The duration of the active state of the G protein, GTP-G␣, is regulated by two different cellular components, the weak GTPase activity of G␣ itself and the catalytic activity of GTPase-activating proteins (GAPs). Regulators of G protein signaling (RGS) act as GAPs for the heterotrimeric G protein ␣ subunit (49). More than 30 RGS proteins have been discovered over the last decade, and they are divided into 8 subfamilies (11,26,52).Among these RGS proteins, RGS2, RGS4, and RGS9-2 are known to be mutually related to the dopaminergic nervous system. It is known that the expression of the genes for RGS2 and RGS4 changes in response to dopaminergic stimulation (43, 44); however, the roles of RGS2 and RGS4 in the signaling and intracellular trafficking of D 2 R and D 3 R have not been...